ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1328

Modulation of Natural IgM-Autoantibodies to Oxidative Stress-Related Neo-Epitopes on Apoptotic Cells in Newborns of Mothers with Anti-Ro Autoimmunity

Caroline Grönwall1, Robert M. Clancy2, Lelise Getu3, Don L. Siegel4, Joanne Reed3, Jill P. Buyon2 and Gregg J. Silverman1, 1Medicine, New York University School of Medicine, New York, NY, 2Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 3New York University School of Medicine, New York, NY, 4Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: autoantibodies, autoimmunity and neonatal lupus

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Pediatric Lupus, Scleroderma and Myositis (ACR)

Session Type: Abstract Submissions (ACR)

Background/Purpose

At birth, the human immune system expresses substantial circulating levels of polymeric IgM that include autoantibodies to oxidation-associated epitopes on apoptotic cells. This study addressed whether the neonatal IgM-repertoire may be affected by exposure to anti-Ro/La IgG-autoantibodies of maternal origin, which in some offspring leads to development of neonatal lupus. 

Methods

Levels of IgM-specificities were compared in 43 healthy adults, and in umbilical cord blood (CB) from 31 unaffected newborns of non-autoimmune mothers and 103 newborns of mothers from the Research Registry for Neonatal Lupus. All mothers enrolled in the Registry have IgG anti-Ro (Ro60 and/or Ro52). In this cohort, 56 fetuses developed cardiac neonatal lupus, 4 neonates had rash, while 40 were clinically unaffected. Sandwich ELISA used phosphorylcholine (PC16)-BSA, malondialdehyde (MDA)-BSA or Ro60, with anti-IgM detection.

Results

IgM-antibodies to oxidation-associated MDA-determinants were relatively more highly represented in control newborns compared to adults (IgM anti-MDA/total IgM 7.2±3.6 CB vs 1.0±0.6 adults) while the ratio IgM anti-PC/total IgM was lower (2.7±1.7 vs 10.7±5.6, p<0.0001). CB levels of IgM anti-MDA directly correlated with IgM binding to apoptotic cells. In neonates exposed to IgG anti-Ro, total IgM and IgM anti-Ro60 were significantly elevated compared to control neonates (41±39 RU/ml vs 27±18, p=0.008; 218±203 RU/ml vs 129±115 RU/ml, p=0.003, respectively). Similarly, the ratio of IgM anti-Ro60 was higher in these newborns compared to controls (8.6±9.6 vs 5.0±2.8, p=0.001). No correlation between IgM and IgG anti-Ro60 or RF IgM in CB could be detected. In contrast, the proportion of IgM anti-MDA was significantly lower in CB from neonates exposed to IgG anti-Ro60 mothers compared to controls (4.8±4.7 vs 7.2±3.6, p=0.004). Neither the development of heart block, nor the disease status of the mothers, was associated with differences in neonatal IgM levels.  

Conclusion

These findings document the relative dominance in the neonate of specificities of IgM-autoantibodies to oxidation-associated neo-determinants associated with protective properties in other settings. These data suggest that early immune development of the natural IgM-repertoire may become imprinted by maternally transferred anti-Ro60 IgG-autoantibodies.


Disclosure:

C. Grönwall,
None;

R. M. Clancy,
None;

L. Getu,
None;

D. L. Siegel,
None;

J. Reed,
None;

J. P. Buyon,
None;

G. J. Silverman,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/modulation-of-natural-igm-autoantibodies-to-oxidative-stress-related-neo-epitopes-on-apoptotic-cells-in-newborns-of-mothers-with-anti-ro-autoimmunity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology